ALHC

A securities fraud investigation into Alignment Healthcare continues following allegations that a former executive filed a whistleblower lawsuit claiming the company manipulated finances by misclassifying operating expenses as capital expenditures to artificially inflate adjusted EBITDA. The stock fell 16.7% on July 8, 2026, following the disclosure.

A whistleblower lawsuit alleges that Alignment Healthcare manipulated its finances by misclassifying $8-10 million in operating expenses as capital expenditures to artificially inflate adjusted EBITDA and report false positive earnings. The stock fell 16.7% on the news, injuring investors.

Alignment Healthcare's stock plummeted 59% between July and October 2026 after CMS downgraded its California HMO plan (H3815) from 4.0 to 3.5 Star Rating, making it ineligible for quality bonus payments. The company faces investor scrutiny over allegedly misleading statements about its confidence in maintaining bonus eligibility, with management refusing to discuss Star Rating positioning in September before the downgrade was publicly disclosed.